1-7 of 7
Michael B. Sporn
Close
Sort by
Journal Articles

CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer–binding protein alpha

Steffen Koschmieder, Francesco D'Alò, Hanna Radomska, Christine Schöneich, Ji Suk Chang, Marina Konopleva, Susumu Kobayashi, Elena Levantini, Nanjoo Suh, Annalisa Di Ruscio, Maria Teresa Voso, Julie C. Watt, Ramasamy Santhanam, Bülent Sargin, Hagop Kantarjian, Michael Andreeff, Michael B. Sporn, Danilo Perrotti, Wolfgang E. Berdel, Carsten Müller-Tidow, Hubert Serve, Daniel G. Tenen
Journal: Blood
Blood (2007) 110 (10): 3695–3705.
https://doi.org/10.1182/blood-2006-11-058941
Published: 2007
Includes: Supplemental data
Journal Articles

CDDO Increases Translation of CCAAT Enhancer Binding Protein alpha To Induce Granulocytic Differentiation.

Steffen Koschmieder, MD, Francesco D′Alo′, MD, Hanna Radomska, PhD, Susumu Kobayashi, MD, PhD, Elena Levantini, PhD, Nanjoo Suh, PhD, Michael B. Sporn, MD, Annalisa Di Ruscio, MD, Maria Teresa Voso, MD, Wolfgang E. Berdel, MD, Carsten Müller-Tidow, MD, Hubert Serve, MD, Daniel G. Tenen, MD
Journal: Blood
Blood (2005) 106 (11): 2458.
https://doi.org/10.1182/blood.V106.11.2458.2458
Published: 2005
Journal Articles

Mechanisms and Activity of PPARγ-Active Triterpenoids CDDO and CDDO-Me in Leukemias.

Marina Konopleva, MD, PhD, Ismael Samudio, PhD, Twee Tsao, Steven M. Kornblau, MD, Yue-Xi Shi, Teresa McQueen, BS, Rooha Contractor, Michael B. Sporn, MD, Colin J. Meyer, MD, Warren Huff, Stephen H. Safe, PhD, Hagop Kantarjian, MD, Michael Andreeff, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2460.
https://doi.org/10.1182/blood.V106.11.2460.2460
Published: 2005
Journal Articles

Retraction: The triterpenoid CDDO-Imidazolide induces apoptosis and enhances fludarabine-induced apoptosis of CLL B-cells

Irene M. Pedersen, Juan M. Zapata, Temesgen Samuel, Fiona L. Scott, Guy S. Salvesen, Tadashi Honda, Gordon W. Gribble, Nanjoo Suh, Michael B. Sporn, Thomas J. Kipps, John C. Reed
Journal: Blood
Blood (2004) 104 (4): 932.
https://doi.org/10.1182/blood-2003-11-3774
Published: 2004
Journal Articles

The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti–multiple myeloma (MM) activity and overcome bortezomib resistance

Dharminder Chauhan, Guilan Li, Klaus Podar, Teru Hideshima, Reshma Shringarpure, Laurence Catley, Constantine Mitsiades, Nikhil Munshi, Yu Tzu Tai, Nanjoo Suh, Gordon W. Gribble, Tadashi Honda, Robert Schlossman, Paul Richardson, Michael B. Sporn, Kenneth C. Anderson
Journal: Blood
Blood (2004) 103 (8): 3158–3166.
https://doi.org/10.1182/blood-2003-08-2873
Published: 2004
Journal Articles

The triterpenoid CDDO induces apoptosis in refractory CLL B cells

Irene M. Pedersen, Shinichi Kitada, Aaron Schimmer, Youngsoo Kim, Juan M. Zapata, Lula Charboneau, Laura Rassenti, Michael Andreeff, Frank Bennett, Michael B. Sporn, Lance D. Liotta, Thomas J. Kipps, John C. Reed
Journal: Blood
Blood (2002) 100 (8): 2965–2972.
https://doi.org/10.1182/blood-2002-04-1174
Published: 2002
Journal Articles

Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia

Marina Konopleva, Twee Tsao, Peter Ruvolo, Irina Stiouf, Zeev Estrov, Clinton E. Leysath, Shourong Zhao, David Harris, Shirong Chang, C. Ellen Jackson, Mark Munsell, Nanjoo Suh, Gordon Gribble, Tadashi Honda, W. Stratford May, Michael B. Sporn, Michael Andreeff
Journal: Blood
Blood (2002) 99 (1): 326–335.
https://doi.org/10.1182/blood.V99.1.326
Published: 2002